S&P 500 Futures Climb In Premarket Trading; Avidity Biosciences, BridgeBio Pharma Lead

Dow Jones
Oct 27

This article was automatically generated by Barrons.com using technology from Automated Insights.

With U.S. stock markets set to open in two hours, Avidity Biosciences Inc. (RNA) was up 43.6% in pre-market trading, and BridgeBio Pharma Inc. (BBIO) was up 10.6%.

GameStop Corp. Cl A $(GME)$, Lumentum Holdings Inc. (LITE), and Fermi Inc. (FRMI) were all posting gains of at least 7%. In early trading, XP Inc. Cl A (XP) and MP Materials Corp. (MP) had posted declines, falling 6.8% and 5.5%, respectively.

Meanwhile S&P 500 futures were up 0.83%, with futures for the Dow Jones Industrial Average rising 0.51%. The Cboe Volatility Index futures were down 0.85%.

In commodities news, Brent crude oil futures were down 0.49%, and gold futures were down 2.31%. Bitcoin climbed 1.44% to $115,240.

The 10-Year Treasury yield rose to 4.034%.

In the previous regular trading session, the S&P 500 and the Dow were up 0.79% and 1.01%, respectively. Stocks in Asia were up overnight, with Japan's NIKKEI 225 Index up 2.46% and China's Shanghai Composite Index rising 1.18%.

In afternoon trading, stocks in Europe are mixed, with the STOXX Europe 600 Index rising 0.07% and the FTSE 100 Index declining 0.01% from the previous close.

U.S. stock markets open for trading at 9:30 a.m. ET.

Data source: Dow Jones Market Data, FactSet. Data compiled October 27, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

October 27, 2025 07:31 ET (11:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10